In an anuric end‑stage renal disease patient receiving hemodialysis on Monday, Wednesday, Friday and Saturday, should an additional cefepime dose be given on Sunday to bridge the three‑day interval before the next dialysis session?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cefepime Bridging Dose on Sunday

Yes, an additional dose of cefepime should be administered on Sunday to bridge the 72-hour interval before Monday's dialysis session. The FDA-approved dosing for hemodialysis patients explicitly accounts for the longer interdialytic interval, and maintaining therapeutic drug levels throughout this period is critical for preventing treatment failure and bacterial resistance.

Dosing Strategy for the 72-Hour Interval

The Sunday dose should be higher than the dose given before 48-hour intervals. According to the FDA label, cefepime is removed approximately 68% during a 3-hour hemodialysis session, necessitating post-dialysis replacement dosing 1. Research demonstrates that doses before 72-hour intervals must be significantly higher than those before 48-hour intervals to maintain adequate drug concentrations 2.

Specific Dosing Recommendations

  • For highly susceptible pathogens (MIC ≤4 mg/L): Administer 1.5 g cefepime post-dialysis on Saturday before the 72-hour interval to Sunday-Monday 2
  • For less susceptible organisms like Pseudomonas aeruginosa (MIC up to 8 mg/L): Administer 2 g cefepime post-dialysis on Saturday, with potential need for an additional bridging dose on Sunday 2, 3
  • The dose before 48-hour intervals (Wednesday-Friday, Friday-Saturday) should be approximately 1 g for susceptible pathogens or 1.5 g for resistant organisms 2

Pharmacokinetic Rationale

The need for Sunday bridging relates to cefepime's elimination kinetics in anuric ESRD patients:

  • Pre-dialysis trough concentrations at 72 hours average 11.3 ± 5.6 mg/L, which may fall below therapeutic targets for organisms with MIC >4 mg/L during the final 24 hours of the interval 2
  • Hemodialysis removes 55-68% of circulating cefepime, reducing concentrations from approximately 64 mg/L to 20 mg/L during a single session 1, 4
  • The elimination half-life in anuric patients is 33.6 hours between dialysis sessions, meaning drug levels decline substantially over 72 hours 4

Clinical Decision Algorithm

Step 1: Identify the pathogen and MIC

  • If MIC ≤4 mg/L: Standard post-dialysis dosing (1.5 g Saturday) without Sunday bridge may suffice 2
  • If MIC 4-8 mg/L or unknown pathogen: Sunday bridging dose is recommended 2, 3
  • If MIC >8 mg/L or Pseudomonas aeruginosa: Sunday bridging dose is mandatory 2, 3

Step 2: Assess residual renal function

  • Anuric patients (as specified in your case): Require higher doses due to complete dependence on dialytic clearance 2
  • Patients with preserved diuresis achieve 40% lower trough levels and may need even more aggressive dosing 2

Step 3: Determine Sunday bridging dose

  • For anuric patients with susceptible organisms: 500-750 mg on Sunday maintains therapeutic levels 3
  • For resistant organisms or critically ill patients: 1 g on Sunday ensures >90% probability of target attainment 3

Critical Pitfalls to Avoid

Never skip the Sunday dose for infections with unknown susceptibility or resistant organisms. Subtherapeutic levels during the 72-hour interval risk treatment failure, particularly for Pseudomonas aeruginosa where maintaining drug concentrations >70% of the time above MIC is essential for bacterial eradication 2, 3.

Do not use the same dose before 48-hour and 72-hour intervals. Research clearly demonstrates that the Saturday dose before the 72-hour interval must be 45% higher (1125 mg vs 775 mg) than doses before 48-hour intervals to maintain equivalent trough concentrations 2.

Avoid administering cefepime before dialysis sessions. The FDA label and clinical guidelines emphasize post-dialysis administration to prevent premature drug removal and facilitate directly observed therapy 1, 5.

Monitoring Considerations

  • Trough levels before Monday dialysis should exceed the EUCAST breakpoint of 8 mg/L for Pseudomonas aeruginosa 2
  • For highly susceptible organisms, trough levels >1 mg/L are adequate 2
  • Peak concentrations immediately post-dose should reach 128-196 mg/L to ensure concentration-dependent killing 2

Related Questions

What is the recommended dose of ceftazidime-avibactam for a patient with Impaired renal function on hemodialysis (HD)?
What is the dosing regimen for ceftazidime-avibactam and aztreonam in patients with impaired renal function (IRF) on hemodialysis (HD)?
What is the recommended dose of cefepime for a patient with End-Stage Renal Disease (ESRD)?
What is the recommended dosing of cefepime for patients with Impaired renal function (IRF) undergoing Hemodialysis (HD)?
What is the recommended dose of Ceftazidime (Ceftazidime) for patients with End-Stage Renal Disease (ESRD)?
Which calcium‑channel blockers are associated with nocturnal muscle cramps or spasms in elderly patients?
What are the current guideline recommendations for managing primary hypertension in adults, including blood pressure targets, lifestyle modifications, first‑line pharmacologic classes, and adjustments for age, race, diabetes, or chronic kidney disease?
What X‑ray views and subsequent management are recommended for an acute traumatic injury to the middle finger with suspected fracture or dislocation?
In an anuric end‑stage renal disease patient receiving hemodialysis on Monday, Wednesday, Friday, and Saturday, should the post‑dialysis cefepime dose on Sunday be increased from 1 g to 2 g?
In a patient with a drained intra‑abdominal abscess cultured positive for Enterococcus faecium, who is already receiving ceftazidime‑avibactam, aztreonam, and metronidazole, what are the safety risks of adding vancomycin versus linezolid and which agent is preferred?
In a patient receiving hemodialysis three times per week, how should I schedule and dose antibiotics to maintain therapeutic levels during the two‑day interval between sessions?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.